Cardiology Search
Cardiology Cardiology
tachycardia
TACHYCARDIA
Treatment Guideline Chart

Tachycardia is defined as a cardiac rate that is increased to >100 beats/minute (bpm).

Tachyarrhythmia is used to describe tachycardia in the presence of cardiac rhythm abnormality.

Divided into supraventricular and ventricular tachycardia.

Signs and symptoms related to rapid heart rate are altered sensorium, angina, shortness of breath, myocardial infarction, hypotension and other signs of shock (eg cold clammy skin, low urine output), heart failure or pulmonary congestion.

Tachycardia References

  1. Delacretaz E. Supraventricular tachycardia. N Engl J Med. 2006 Mar;354(10):1039-1051. doi: 10.1056/NEJMcp051145. PMID: 16525141
  2. January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec;64(21):e1-e76. doi:10.1016/j.jacc.2014.03.022. Accessed 27 Jan 2017. PMID: 24685669
  3. Page RL, Joglar JA, Caldwell MA, et al; Evidence Review Committee Chair. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Sep 23, 2015. Circulation. 2016 Apr;133(14):e506-e574. doi: 10.1161/CIR.0000000000000311. Accessed 27 Jan 2017. PMID: 26399663
  4. Miller JM, Zipes DP. Diagnosis of cardiac arrhythmias. In: Mann DL, Zipes DP, Libby P, et al, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2015:662-684.
  5. Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Mann DL, Zipes DP, Libby P, et al, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2015:748-797.e2.
  6. American Heart Association. Tachycardia - fast heart rate. American Heart Association. http://www.heart.org/. Dec 2016. Accessed 27 Jan 2017.
  7. Buxton A. Multifocal atrial tachycardia. UpToDate. https://www.uptodate.com/. Sep 2015. Accessed 27 Jan 2017.
  8. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 Oct;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Accessed 27 Jan 2017. PMID: 27567408
  9. Morady F, Zipes DP. Atrial fibrillation: clinical features, mechanisms, and management. In: Mann DL, Zipes DP, Libby P, et al. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2015:798-820.
  10. Priori SG, Blomström-Lundqvist C. 2015 European Society of Cardiology guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J. 2015 Nov;36(41):2757-2759. doi: 10.1093/eurheartj/ehv445. Accessed 27 Jan 2017. PMID: 26745817
  11. Prutkin JM. Overview of the acute management of tachyarrhythmias. UpToDate. https://www.uptodate.com/. 03 Jan 2020. Accessed 27 Jan 2017.
  12. Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015 Jun;12(6):e41-63. doi: 10.1016/j.hrthm.2015.03.029. Accessed 27 Jan 2017. PMID: 25980576
  13. Von Bergen N, Law IH, Dick M. Atrial flutter intra-atrial reentrant tachycardia. In: Dick M. Clinical Cardiac Electrophysiology in the Young. New York, USA: Springer Science+Business Media New York; 2015:123.
  14. American Academy of Family Physicians. Updated clinical practice guideline: pharmacologic management of newly detected atrial fibrillation. AAFP. http://www.aafp.org/. Apr 2017. Accessed 15 Aug 2017.
  15. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 May. doi: 10.1016/j.hrthm.2017.05.012. Accessed 15 Aug 2017. PMID: 28506916
  16. Doherty JU, Gluckman TJ, Hucker WJ, et al. 2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017 Feb;69(7):871-898. doi: 10.1016/j.jacc.2016.11.024. Accessed 15 Aug 2017. PMID: 28081965
  17. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 Oct;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054.
  18. Chiang CE, Okumura K, Zhang S, et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm. 2017 Aug;33(4):345-367. doi: 10.1016/j.joa.2017.05.004. PMID: 28765771
  19. Di Biase L, Walsh EP. Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway. UpToDate. https://www.uptodate.com. Feb 2018. Accessed 28 Dec 2018.
  20. Frisch DR, Zimetbaum PJ. Vagal maneuvers. UpToDate. https://www.uptodate.com. Apr 2018. Accessed 09 Jan 2019.
  21. Ganz, LI. Narrow QRS complex tachycardias: clinical manifestations, diagnosis, and evaluation. UpToDate. https://www.uptodate.com. 04 Sep 2018. Accessed 28 Dec 2018.
  22. Ganz, LI. Wide QRS complex tachycardias: approach to the diagnosis. UpToDate. https://www.uptodate.com. 03 May 2018. Accessed 28 Dec 2018.
  23. Ganz, LI. Wide QRS complex tachycardias: approach to management. UpToDate. https://www.uptodate.com. 26 Sep 2018. Accessed 14 Jan 2019.
  24. Hauk L. Newly detected atrial fibrillation: AAFP updates guideline on pharmacologic management. Am Fam Physician. 2017 Sep;96(5):332-333. https://www.aafp.org. Accessed 28 Dec 2018. PMID: 28925646
  25. Helton MR. Diagnosis and management of common types of supraventricular tachycardia. Am Fam Physician. 2015 Nov;92(9):793-800. https://www.aafp.org. Accessed 28 Dec 2018. PMID: 26554472
  26. Homoud MK. Intraatrial reentrant tachycardia. UpToDate. https://www.uptodate.com. 14 Sep 2017. Accessed 28 Dec 2018.
  27. Homoud MK. Sinoatrial nodal reentrant tachycardia (SANRT). UpToDate. https://www.uptodate.com. 14 Sep 2017. Accessed 28 Dec 2018.
  28. Homoud MK. Sinus tachycardia. UpToDate. https://www.uptodate.com. 12 Mar 2020. Accessed 28 Dec 2018.
  29. Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Europace. 2017 Mar;19(3):465-511. doi: 10.1093/europace/euw301. Accessed 2 Jan 2019. PMID: 27856540
  30. Kistler P. Focal atrial tachycardia. UpToDate. https://www.uptodate.com. 20 Sep 2018. Accessed 28 Dec 2018.
  31. Knight BP. Atrioventricular nodal reentrant tachycardia. UpToDate. https://www.uptodate.com. 12 Sep 2018. Accessed 28 Dec 2018.
  32. Kumar K. Overview of atrial fibrillation: recommendations. UpToDate. https://www.uptodate.com. 04 Sep 2018. Accessed 14 Jan 2019.
  33. Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. PMID: 30144419
  34. Lip GYH, Collet JP, Haude M, et al. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace. 21 Jul 2018. doi: 10.1093/europace/euy174. Accessed 02 Jan 2019. PMID: 30052888
  35. Miller JM, Tomaselli GF, Zipes DP. Diagnosis of cardiac arrhythmias. In: Zipes DP, Libby P, Bonow RO, et al, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2019. Accessed 16 Jan 2019:648-669.
  36. Naccarelli GV. Atrial fibrillation: cardioversion to sinus rhythm. UpToDate. https://www.uptodate.com. Jun 2018. Accessed 14 Jan 2019.
  37. NHFA CSANZ Atrial Fibrillation Guideline Working Group. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ. 2018 Oct;27(10):1209-1266. doi: 10.1016/j.hlc.2018.06.1043. PMID: 30077228
  38. Neumar RW, Otto CC, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010 Nov;122(18)(Suppl 3):729-767. doi: 10.1161/CIRCULATIONAHA.110.970988. Accessed 13 Jan 2019. PMID: 20956224
  39. Prutkin JM. Overview of the management of tachyarrhythmias. UpToDate. https://www.uptodate.com. 29 Nov 2018. Accessed 28 Dec 2018.
  40. Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018 Apr;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136. PMID: 29562325
  41. Tomaselli GF, Zipes DP. Approach to the patient with cardiac arrhythmias. In: Zipes DP, Libby P, Bonow RO, et al, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2019. 597-603. Accessed 16 Jan 2019:597-603.
  42. Nolan JP, Soar J, Zideman DA, et al. European Resuscitation Council guidelines for resuscitation 2010 section 1. Executive summary. Resuscitation. 2010 Oct;81(10):1219-1276. doi: 10.1016/j.resuscitation.2010.08.021. Accessed 24 Jan 2019. PMID: 20956052
  43. Berul CI. Acquired long QT syndrome: definitions, causes and pathophysiology. UpToDate. https://www.uptodate.com. Jan 2018. Accessed 24 Apr 2019.
  44. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019 Jul 9;74(1):104-132. doi: 10.1016/j.jacc.2019.01.011. Accessed 04 Feb 2019. PMID: 30703431
  45. Mirvis DM, Goldberger AL. Electrocardiography. In: Zipes DP, Libby P, Bonow RO, et al. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2019. Accessed 25 Apr 2019:117-153.
  46. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015 Nov;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. PMID: 26320108
  47. Rautaharju PM, Surawicz B, Gates LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009 Mar;53(11):982-991. doi: 10.1016/j/jacc.2008.12.014. PMID: 19281931
  48. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425. Accessed 10 Sep 2019. PMID: 31504439
  49. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. ESC. http://www.escardio.org. 31 Aug 2019.
  50. American Heart Association. Part 7.3: management of symptomatic bradycardia and tachycardia. Circulation. 2005 Dec;112:IV-67-IV-77. doi: 10.1161/CIRCULATIONAHA.105.166558.
  51. Brinavess (vernakalant) [product monograph]. Cipher Pharmaceuticals. Mississauga, Ontario, Canada: Cipher Pharmaceuticals; 2018 Jul.
  52. Callans DJ. Ventricular tachycardia in the absence of apparent structural heart disease. UpToDate. https://www.uptodate.com. 17 Oct 2018. Accessed 27 Nov 2019.
  53. Camm AJ, Lip GYH, De Caterina R, et al. 2012 Focused update of the ESC guidelines for the management of atrial fibrillation. Eur Heart J. 2012 Nov;33(21):2719-2747. doi: 10.1093/eurheartj/ehs253. PMID: 22922413
  54. Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement of catheter ablation of ventricular arrhythmias. Europace. 2019 Aug 1;21(8):1143-1144. doi: 10.1093/europace/euz132. Accessed 25 Nov 2019. PMID: 31075787
  55. Frost JL, Campos-Outcalt D, Hoelting D, et al. AAFP pharmacologic management of newly detected atrial fibrillation. An updated clinical practice guideline from the American Academy of Family Physicians. Ann Fam Med. 2017 Sep;15(5):490-491. doi: 10.1370/afm.2146. Accessed 25 Nov 2019
  56. Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 2001 Oct;104(17):2118-2150. PMID: 11673357
  57. Ganz LI. Control of ventricular rate in atrial fibrillation: pharmacologic therapy. UpToDate. https://www.uptodate.com. 15 May 2018. Accessed 27 Nov 2019.
  58. Ganz LI. Implantable cardioverter-defibrillators: overview of indications, components, and functions. UpToDate. https://www.uptodate.com. 10 Apr 2019. Accessed 27 Nov 2019.
  59. Gillis AM, Verma A, Talajic M, et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol. 2011 Jan;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001. PMID: 21329862
  60. King DE, Dickerson LM, Sack JL. Acute management of atrial fibrillation: Part 1. Rate and rhythm control. Am Fam Physician. 2002 Jul;66(2):249-256. https://www.aafp.org. PMID: 12152960
  61. Kwong RY. Cardiovascular magnetic resonance imaging. In: Zipes DP, Libby P, Bonow RO, et al, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, Pennsylvania, USA: Saunders, Elsevier; 2019. Accessed 16 Jan 2019:301-319.
  62. Law IH, Dick M. Intra-atrial reentrant tachycardia – atrial flutter. In: Dick M. Clinical Cardiac Electrophysiology in the Young. Developments in Cardiovascular Medicine. Boston, MA: Springer; 2006. Accessed 27 Nov 2019:95-113.
  63. Naccarelli GV, Kowey PR. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS. Curr Cardiol Rev. 2014 Nov;10(4):303-308. doi: 10.2174/1573403X10666140513110247. PMID: 24821656
  64. Phang R, Prutkin JM, Ganz LI. Overview of atrial flutter. UpToDate. https://www.uptodate.com. 05 May 2017.
  65. Stiles MK. Implantable cardioverter-defibrillators: optimal programming. UpToDate. https://www.uptodate.com. 08 Jan 2018. Accessed 27 Nov 2019.
  66. U.S. Food & Drug Administration (US FDA). FDA drug safety communication: FDA study of Medicare patients finds risks lower for stroke and death but higher for gastrointestinal bleeding with Pradaxa (dabigatran) compared to warfarin. US FDA. https://www.fda.gov. 13 May 2014. Accessed 05 Aug 2020.
  67. Hindricks G, Potpara T, Dagres N, et al; ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021 Feb;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Accessed 18 May 2021. PMID: 32860505
  68. ClinicalKey. Clinical overview: atrial fibrillation. ClinicalKey. http://www.clinicalkey.com. 12 Apr 2021.
  69. Deyell MW, AbdelWahab A, Angaran P, et al; Members of the Secondary Panel. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease. Can J Cardiol. 2020 Jun;36(6):822-836. doi: 10.1016/j.cjca.2020.04.004. Accessed 18 May 2021. PMID: 32536373
  70. National Institute for Health and Care Excellence (NICE). Atrial fibrillation: diagnosis & management. NICE. http://www.nice.org.uk/. Apr 2021. Accessed 18 May 2021.
  71. Schevchuck A, Andre P. Tachycardias. In: Kellerman RD, Rakel D, eds. Conn's Current Therapy 2021. Philadelphia: Elsevier; 2021. Accessed 18 May 2021:150-155.
  72. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Accessed 15 Dec 2021. PMID: 34447992
  73. Visseren FLJ, Mach F, Smulders YM, et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Accessed 15 Dec 2021. PMID: 34458905
  74. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021 Sep;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364. Accessed 10 Jan 2022. PMID: 34455430
  75. Homoud MK. Sinus tachycardia: evaluation and management. UpToDate. https://www.uptodate.com. 13 Apr 2018.
Editor's Recommendations
Special Reports
MORE Special Reports arrow
Related Disease News
MORE Disease News arrow